These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

605 related articles for article (PubMed ID: 22260632)

  • 1. Secondary cutaneous Epstein-Barr virus-associated diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma: a case report and review of literature.
    Yang QX; Pei XJ; Tian XY; Li Y; Li Z
    Diagn Pathol; 2012 Jan; 7():7. PubMed ID: 22260632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffuse large B-cell lymphoma in patient after treatment of angioimmunoblastic T-cell lymphoma.
    Skugor ND; Perić Z; Vrhovac R; Radić-Kristo D; Kardum-Skelin I; Jaksić B
    Coll Antropol; 2010 Mar; 34(1):241-5. PubMed ID: 20432757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr Virus-Induced Cutaneous Diffuse Large B-Cell Lymphoma in a Patient With Angioimmunoblastic T-Cell Lymphoma.
    Poon F; Ieremia E; Collins G; Matin RN
    Am J Dermatopathol; 2019 Dec; 41(12):927-930. PubMed ID: 31599749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary Cutaneous Epstein-Barr Virus-associated Diffuse Large B-cell Lymphoma with Hodgkin/Reed-Sternberg-like Cells in a Patient with Angioimmunoblastic T-cell Lymphoma.
    Chen H; Xue YN; Xin CM; Xiong JS; Ni X; Sun JF
    Acta Derm Venereol; 2018 Nov; 98(10):981-982. PubMed ID: 29956714
    [No Abstract]   [Full Text] [Related]  

  • 5. Cutaneous involvement by angioimmunoblastic T-cell lymphoma with remarkable heterogeneous Epstein-Barr virus expression.
    Brown HA; Macon WR; Kurtin PJ; Gibson LE
    J Cutan Pathol; 2001 Sep; 28(8):432-8. PubMed ID: 11493382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting intratumoral B cells with rituximab in addition to CHOP in angioimmunoblastic T-cell lymphoma. A clinicobiological study of the GELA.
    Delfau-Larue MH; de Leval L; Joly B; Plonquet A; Challine D; Parrens M; Delmer A; Salles G; Morschhauser F; Delarue R; Brice P; Bouabdallah R; Casasnovas O; Tilly H; Gaulard P; Haioun C
    Haematologica; 2012 Oct; 97(10):1594-602. PubMed ID: 22371178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus (EBV) positive diffuse large B cell lymphoma of the elderly-experience of a single center from Turkey.
    Ozsan N; Cagirgan S; Saydam G; Gunes A; Hekimgil M
    Pathol Res Pract; 2013 Aug; 209(8):471-8. PubMed ID: 23726928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Composite B-cell and T-cell lymphomas: clinical, pathological, and molecular features of three cases and literature review.
    Jin X; Liu H; Li J; Xiao X; Yuan X; Chen P; Chen B; Liang Y; Huang F
    J Zhejiang Univ Sci B; 2023 Aug; 24(8):711-722. PubMed ID: 37551557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic appearance of AIDS-related gastrointestinal lymphoma with c-MYC rearrangements: case report and literature review.
    Tanaka S; Nagata N; Mine S; Igari T; Kobayashi T; Sugihara J; Honda H; Teruya K; Kikuchi Y; Oka S; Uemura N
    World J Gastroenterol; 2013 Aug; 19(29):4827-31. PubMed ID: 23922484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histologic transformation of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly.
    Lee E; Kim TM; Lim Y; Jeon YK; Go H; Kim CW; Heo DS
    J Clin Oncol; 2013 Jul; 31(19):e332-4. PubMed ID: 23715578
    [No Abstract]   [Full Text] [Related]  

  • 11. The Prognostic Role of Circulating Epstein-Barr Virus DNA Copy Number in Angioimmunoblastic T-Cell Lymphoma Treated with Dose-Adjusted EPOCH.
    Liang JH; Lu L; Zhu HY; Li W; Fan L; Li JY; Xu W
    Cancer Res Treat; 2019 Jan; 51(1):150-157. PubMed ID: 29621877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical impact of serum survivin positivity and tissue expression of EBV-encoded RNA in diffuse large B-cell lymphoma patients treated with rituximab-CHOP.
    Hong JY; Ryu KJ; Park C; Hong M; Ko YH; Kim WS; Kim SJ
    Oncotarget; 2017 Feb; 8(8):13782-13791. PubMed ID: 28099151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of angioimmunoblastic T-cell lymphoma after treatment of diffuse large B-cell lymphoma: a case report and review of literature.
    Wang Y; Xie B; Chen Y; Huang Z; Tan H
    Int J Clin Exp Pathol; 2014; 7(6):3432-8. PubMed ID: 25031772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus-induced transformation of cutaneous plasmacytoma into CD30+ diffuse large B-cell lymphoma.
    Donner LR
    Am J Dermatopathol; 2004 Feb; 26(1):63-6. PubMed ID: 14726824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential development of diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma.
    Huang J; Zhang PH; Gao YH; Qiu LG
    Diagn Cytopathol; 2012 Apr; 40(4):346-51. PubMed ID: 21472868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete Remission and Long-term Survival of a Patient with a Diffuse Large B-cell Lymphoma Under
    Gutsch J; Werthmann PG; Rosenwald A; Kienle GS
    Anticancer Res; 2018 Sep; 38(9):5363-5369. PubMed ID: 30194190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10.
    Attygalle A; Al-Jehani R; Diss TC; Munson P; Liu H; Du MQ; Isaacson PG; Dogan A
    Blood; 2002 Jan; 99(2):627-33. PubMed ID: 11781247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histologic evolution of angioimmunoblastic T-cell lymphoma in consecutive biopsies: clinical correlation and insights into natural history and disease progression.
    Attygalle AD; Kyriakou C; Dupuis J; Grogg KL; Diss TC; Wotherspoon AC; Chuang SS; Cabeçadas J; Isaacson PG; Du MQ; Gaulard P; Dogan A
    Am J Surg Pathol; 2007 Jul; 31(7):1077-88. PubMed ID: 17592275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of refractory retroperitoneal Epstein-Barr virus-positive diffuse large B-cell lymphoma with secondary hemophagocytic syndrome by sequential combination regimen of PD-1 blockade and chimeric antigen receptor T cells: a case report.
    Yu M; Zhang Q; Xu S; Yin T; Li F
    Anticancer Drugs; 2022 Jan; 33(1):e769-e775. PubMed ID: 34387604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of rituximab on treatment outcomes of patients with angioimmunoblastic T-cell lymphoma; a population-based analysis.
    Meeuwes FO; Brink M; van der Poel MWM; Kersten MJ; Wondergem M; Mutsaers PGNJ; Böhmer L; Woei-A-Jin S; Visser O; Oostvogels R; Jansen PM; Diepstra A; Snijders TJF; Plattel WJ; Huls GA; Vermaat JSP; Nijland M
    Eur J Cancer; 2022 Nov; 176():100-109. PubMed ID: 36208568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.